Note: Ingredients listed on restricted chemical lists
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
<1
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
<1
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%< >=5% <5% 0.5%<
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% 017-002- >=25% <25% >=10%
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
10%<=C<25%
EC/CAS
231-598-3/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
*
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
General Information
Version
9
Revision date
2025-07-26
Product name
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/ml
Product name
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/ml
Identification on the label/Trade name
DEPO-PROVERA; DEPO-PRODASONE; FARLUTAL; FARLUTAL DEPO; ONCO-PROVERA; DEPO-RALOVERA; SAYANA; DEPOCON; D-CLINOVIR
Product Synonyms
Medroxyprogesterone Suspension, For Injection, IM
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product used as contraceptive agent
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360FD, H380, H402, H412, H430
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture GHS - Classification Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1A - (H360FD) Endocrine disruption for human health Category 1 - (H380) Hazardous to the aquatic environment - acute Category 3 - (H402) Hazardous to the aquatic environment - chronic Category 3 - (H412) Endocrine disruption for the environment Category 1 - (H430)
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Danger
Hazard statements
H351 - Suspected of causing cancer H360FD - May damage fertility. May damage the unborn child H412 - Harmful to aquatic life with long lasting effects EUH430 - May cause endocrine disruption in the environment
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P263 - Avoid contact during pregnancy/while nursing P273 - Avoid release to the environment P280 - Wear protective gloves and protective clothing P308 + P313 - IF exposed or concerned: Get medical advice/attention P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Chemical name Contains a known or suspected endocrine disruptor.
2.1 Classification of the substance or mixture
GHS - Classification. Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1A - (H360FD) Endocrine disruption for human health Category 1 - (H380) Hazardous to the aquatic environment - acute Category 3 - (H402) Hazardous to the aquatic environment - chronic Category 3 - (H412) Endocrine disruption for the environment Category 1 - (H430) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
